Myocardial Expression Levels of Micro-Ribonucleic Acids in Patients With Left Ventricular Assist Devices: Signature of Myocardial Recovery, Signature of Reverse Remodeling, or Signature With No Name?
- 22 November 2011
- journal article
- editorial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 58 (22), 2279-2281
- https://doi.org/10.1016/j.jacc.2011.09.007
Abstract
No abstract availableFunding Information
- National Institutes of Health (RO1 HL58081, RO1 HL61543, RO1 HL-42250)
This publication has 16 references indexed in Scilit:
- A Micro-Ribonucleic Acid Signature Associated With Recovery From Assist Device Support in 2 Groups of Patients With Severe Heart FailureJournal of the American College of Cardiology, 2011
- In search of new therapeutic targets and strategies for heart failure: recent advances in basic scienceThe Lancet, 2011
- Role of MicroRNAs in Cardiac Remodeling and Heart FailureCardiovascular Drugs and Therapy, 2011
- Mechanical Support in Dilated Cardiomyopathy: Signs of Early Left Ventricular RecoveryThe Annals of Thoracic Surgery, 1997
- Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart diseaseThe Lancet, 1997
- Reversal of Chronic Ventricular Dilation in Patients With End-Stage Cardiomyopathy by Prolonged Mechanical UnloadingCirculation, 1995
- Effects of Long-term Enalapril Therapy on Cardiac Structure and Function in Patients With Left Ventricular DysfunctionCirculation, 1995
- Reverse Remodeling From Cardiomyoplasty in Human Heart FailureCirculation, 1995
- First use of an untethered, vented electric left ventricular assist device for long-term support.Circulation, 1994
- Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.Circulation, 1993